Breast cancer has been the subject of sustained clinical investigation across multiple research sites.

221 total trials for this combination

Showing top 10 of 221 trials

Trials

NCT ID	Title	Status	Phase
NCT02568267	Basket Study of Entrectinib (RXDX-101) for the Treatment of Patients With Solid Tumors Harboring NTRK 1/2/3 (Trk A/B/C), ROS1, or ALK Gene Rearrangements (Fusions)	ACTIVE_NOT_RECRUITING	PHASE2
NCT05879926	Evaluating the Addition of Adjuvant Chemotherapy to Ovarian Function Suppression Plus Endocrine Therapy in Premenopausal Patients With pN0-1, ER-Positive/HER2-Negative Breast Cancer and an Oncotype Recurrence Score Less Than or Equal to 25	RECRUITING	—
NCT06492616	A Study of Elacestrant Versus Standard Endocrine Therapy in Women and Men With ER+,HER2-, Early Breast Cancer With High Risk of Recurrence	RECRUITING	—
NCT00417040	Collection of Patient-Reported Symptoms and Performance Status Via the Internet	COMPLETED	NA
NCT06492616	A Study of Elacestrant Versus Standard Endocrine Therapy in Women and Men With ER+,HER2-, Early Breast Cancer With High Risk of Recurrence	RECRUITING	—
NCT03452774	SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry	RECRUITING	—
NCT02628535	Safety Study of MGD009 in B7-H3-expressing Tumors	TERMINATED	PHASE1
NCT05879926	Evaluating the Addition of Adjuvant Chemotherapy to Ovarian Function Suppression Plus Endocrine Therapy in Premenopausal Patients With pN0-1, ER-Positive/HER2-Negative Breast Cancer and an Oncotype Recurrence Score Less Than or Equal to 25	RECRUITING	—
NCT03155997	Endocrine Therapy With or Without Abemaciclib (LY2835219) Following Surgery in Participants With Breast Cancer	ACTIVE_NOT_RECRUITING	—
NCT00003162	Radiation Therapy in Treating Patients With Bone Metastases From Breast or Prostate Cancer	COMPLETED	PHASE3

Related Pages

All Breast cancer trials All trials in San Francisco, United States